Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

February 22, 2018 - 5:01 p.m.
Gilead Sciences Announces Senior Management ChangePrinter Friendly Version 
February 22, 2018 - 7:01 a.m.
Kite, a Gilead Company, and Sangamo Therapeutics Announce Collaboration to Develop Next-Generation Engineered Cell Therapies for the Treatment of CancerPrinter Friendly Version 

Upcoming Events

Sunday, March 4, 2018 through Wednesday, March 7, 2018
Conference on Retroviruses and Opportunistic Infections (CROI) 2018
LocationBoston, MA

Most Viewed Links

Updated 02/25/18
1.SEC Filings
2.Annual Reports
3.Earnings
4.Fundamentals - Snapshot
5.Kite, a Gilead Company, and Sangamo Therapeutics Announce Collaboration to Develop Next-Generation Engineered Cell Therapies for the Treatment of Cancer
* Data collected 02/17/18 - 02/24/18

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$80.91
 Stock is Up 1.51 (1.90%)
Data as of 02/23/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at the RBC Capital Markets 2018 Global Healthcare Conference

February 21, 2018 9:00 a.m. ET
Play
Fourth Quarter 2017 Gilead Sciences Earnings Conference Call

February 06, 2018 4:30 p.m. ET
Play
36th Annual J.P. Morgan Healthcare Conference

January 08, 2018 3:30 p.m. PT
Play
Credit Suisse 26th Annual Healthcare Conference

November 07, 2017 12:30 p.m. MT
Play